arrow
M

Martin Stanulla

university of hannover
H指数:72
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-Dose Methotrexate at All Ages: Safety, Efficacy, and Outcomes from the HDMTX European Registry

全年龄段大剂量甲氨蝶呤:欧洲HDMTX登记研究的安全性、有效性与结局

Cancers
IF4.4
2025-12-310
OAAI
Results in pediatric T-ALL patients treated in trial AIEOP-BFM ALL 2009: Prognostic factors in the context of modern risk-adapted therapy

AIEOP-BFM ALL 2009试验中接受治疗的儿童T-ALL患者的结果:现代风险适应疗法背景下的预后因素

2025-09-020
OAAI
SOD2 is a regulator of proteasomal degradation promoting an adaptive cellular starvation response

SOD2是蛋白酶体降解的调控因子,促进适应性细胞饥饿反应。

2025-04-010
PRE
Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL

亚克隆TP53和KRAS变异与不良治疗反应相结合,可识别出T-ALL超高危儿科患者

2025-01-140
OA
Results in Pediatric T-ALL Patients Treated in Trial AIEOP-BFM ALL 2009: Exploring Prognostic Factors in the Context of Modern Risk Adapted Therapy

儿童T-ALL患者在接受AIEOP-BFM ALL 2009试验治疗后的结果:在现代化风险适应治疗背景下探索预后因素

BLOOD
IF23.1
2024-11-050
PRE
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL
2024-05-310
OAAI
Proteogenomic profiling uncovers differential therapeutic vulnerabilities between TCF3::PBX1 and TCF3::HLF translocated B-cell acute lymphoblastic leukemia
2024-02-290
OAAI
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children With Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction
2023-06-013
OAAI
Definition and Prognostic Value of Ph-like and IKZF1plus Status in Children With Down Syndrome and B-cell Precursor Acute Lymphoblastic Leukemia

Ph样和IKZF1plus状态在儿童唐氏综合征和b细胞前体急性淋巴细胞白血病中的定义和预后价值

2023-06-019
OAAI
The KMT2A recombinome of acute leukemias in 2023
LEUKEMIA
IF13.4
2023-04-0566
OAAI
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study group

小儿急性淋巴细胞白血病的化疗相关高胆红素血症: aieop-bfm ALL研究组的全基因组关联研究

2023-01-133
OAAI
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosis
2022-08-227
OAAI